Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States.
暂无分享,去创建一个
C. Porta | R. Montironi | F. Massari | M. Santoni | S. Bracarda | F. Piva | E. Grande | M. Giulietti | M. Rizzo | M. Matrana | V. Mollica | G. Aurilio | D. Heng
[1] Anas M. Saad,et al. Trends in Renal‐Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER‐Based Study , 2019, Clinical genitourinary cancer.
[2] D. Zou,et al. miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma , 2018, Journal of Cancer.
[3] E. Arias,et al. Mortality in the United States, 2016. , 2017, NCHS data brief.
[4] B. Shuch,et al. Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test , 2017, Cancer.
[5] K. Inamura. Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification , 2017, International journal of molecular sciences.
[6] Brian M. Owens. Kidney cancer , 2016, Nature.
[7] Hong Zheng,et al. Prediction and diagnosis of renal cell carcinoma using nuclear magnetic resonance-based serum metabolomics and self-organizing maps , 2016, Oncotarget.
[8] Holger Moch,et al. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours. , 2016, European urology.
[9] L. Fazli,et al. DHH is an independent prognosticator of oncologic outcome of clear cell renal cell carcinoma. , 2014, The Journal of urology.
[10] Alexandra Wollum,et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. , 2014, JAMA.
[11] Alexander D. Romaschin,et al. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma , 2014, Oncotarget.
[12] C. Porta. How to identify active novel agents in rare cancers and then make them available: a need for a paradigm shift. , 2012, European urology.
[13] E. Mikros,et al. (1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool. , 2010, Journal of proteome research.
[14] Wong-Ho Chow,et al. Epidemiology and risk factors for kidney cancer , 2010, Nature Reviews Urology.
[15] Benjamin Caballero,et al. Will All Americans Become Overweight or Obese? Estimating the Progression and Cost of the US Obesity Epidemic , 2008, Obesity.
[16] Yiran Huang,et al. Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis. , 2008, Analytica chimica acta.
[17] Jigneshkumar L Patel,et al. Applications of artificial neural networks in medical science. , 2007, Current clinical pharmacology.
[18] F. Guillé,et al. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. , 2007, European urology.
[19] A. Valéri,et al. Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival. , 2007, European urology.
[20] J. Bongaarts. How Long Will We Live , 2006 .
[21] Antonio Lopez-Beltran,et al. 2004 WHO classification of the renal tumors of the adults. , 2006, European urology.
[22] C. Wood,et al. Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma. , 2004, The Journal of urology.
[23] P. Selby,et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. , 2003, Cancer research.
[24] J. Wilmoth. Demography of longevity: past, present, and future trends , 2000, Experimental Gerontology.
[25] P. Godley,et al. Renal cell carcinoma. , 2002, Current opinion in oncology.